SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-009127
Filing Date
2012-02-15
Accepted
2012-02-15 16:36:06
Documents
1
Period of Report
2012-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd334186.html 4  
1 FORM 4 rrd334186.xml 4 8820
  Complete submission text file 0001181431-12-009127.txt   11144
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Reporting) CIK: 0000014272 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50772 | Film No.: 12616426
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Issuer) CIK: 0001274913 (see all company filings)

IRS No.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 (212) 546-4000
Inta Acquisition Corp (Reporting) CIK: 0001539753 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-50772 | Film No.: 12616425